Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 1

1(12.5%)

8Total

N/A(7)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04982874Not ApplicableCompleted

Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers

Role: collaborator

NCT05849883Not ApplicableCompleted

Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject

Role: collaborator

NCT05753371Not ApplicableCompleted

Bioequivalence Study of Metformin Hydrochloride 500 mg Film-Coated Tablets in Indonesia Healthy Subject

Role: collaborator

NCT04988646Not ApplicableCompleted

Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject

Role: collaborator

NCT05468879Not ApplicableCompleted

Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects

Role: collaborator

NCT04964193Not ApplicableCompleted

Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

Role: collaborator

NCT04982861Not ApplicableCompleted

Bioequivalence Study of Cefixime Trihydrate Dry Syrup in Indonesia Healthy Volunteers

Role: collaborator

NCT04134676Phase 1Completed

Therapeutic Potential of Stem Cell Conditioned Medium on Chronic Ulcer Wounds

Role: collaborator

All 8 trials loaded